BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33895936)

  • 1. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
    Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
    Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design its Skin Distribution Studies, Dermatokinetic Modeling & In-Vitro and Ex-Vivo Correlation.
    Bhargav E; Reddy YP; Koteshwara KB
    Curr Drug Deliv; 2021; 18(7):1041-1053. PubMed ID: 33319682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
    Rapalli VK; Sharma S; Roy A; Singhvi G
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
    Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA
    Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and dermatokinetic assessment.
    Mahmood A; Rapalli VK; Waghule T; Gorantla S; Singhvi G
    Chem Phys Lipids; 2021 Jan; 234():105028. PubMed ID: 33309940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
    Madan JR; Khobaragade S; Dua K; Awasthi R
    Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 Jul; 12(7):1753-1773. PubMed ID: 34671949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic development and characterization of curcumin-loaded nanogel for topical application.
    Kesharwani P; Jain A; Srivastava AK; Keshari MK
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1443-1457. PubMed ID: 32644836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
    Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
    Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies.
    Pant A; Sharma G; Saini S; Kaur G; Jain A; Thakur A; Singh B
    Drug Deliv Transl Res; 2024 Mar; 14(3):730-756. PubMed ID: 37768530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation.
    Rajpoot K; Prajapati SK; Malaiya A; Jain R; Jain A
    AAPS PharmSciTech; 2022 Aug; 23(7):241. PubMed ID: 36008695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
    Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
    Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical caffeine-loaded nanostructured lipid carriers for enhanced treatment of cellulite: A 3
    Kassem AA; Asfour MH; Abd El-Alim SH; Khattab MA; Salama A
    Int J Pharm; 2023 Aug; 643():123271. PubMed ID: 37499772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.